Key terms

About ANIX

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ANIX news

Mar 22 4:42pm ET Anixa Biosciences Stockholders Affirm Confidence and Oversight by TipRanks Mar 21 6:17am ET Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances by TipRanks Mar 18 3:06pm ET Fly Insider: Crocs, Best Buy among week’s notable insider trades by TipRanks Feb 13 12:20pm ET Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD) by TipRanks Feb 12 7:32am ET Anixa Biosciences begins dosing in second cohort of ovarian cancer CAR-T trial by TipRanks Jan 23 7:58am ET Anixa Biosciences granted ovarian cancer vaccine technology patent in Japan by TipRanks Jan 04 2:07pm ET Meet Anixa Biosciences: Fly exclusive interview with CEO Amit Kumar by TipRanks Jan 04 2:00pm ET Commercialization through large partner among Anixa goals, CEO tells The Fly by TipRanks Jan 04 2:00pm ET Anixa could begin human testing for ovarian cancer vaccine by 2025, CEO says by TipRanks Jan 04 2:00pm ET Anixa CEO says breast cancer vaccine data looking ‘incredibly promising’ by TipRanks Jan 04 2:00pm ET Anixa looking to change cancer landscape with preventive vaccines, CEO says by TipRanks

No recent press releases are available for ANIX

ANIX Financials

1-year income & revenue

Key terms

ANIX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ANIX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming